Qiwei Chen

Dalian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Retraction notice to "Prediction of bladder cancer prognosis and immune microenvironment assessment using machine learning and deep learning models" [Heliyon 10 (2024) e39327].

Retraction notice to "Prediction of bladder cancer prognosis and immune microenvironment assessment using machine learning and deep learning models" [Heliyon 10 (2024) e39327].

Journal: Heliyon

Published: August 12, 2026

Liquid-liquid phase separation-associated gene networks link EMT and ferroptosis to define a PDGFRB-centered prognostic signature in bladder cancer.

Liquid-liquid phase separation-associated gene networks link EMT and ferroptosis to define a PDGFRB-centered prognostic signature in bladder cancer.

Journal: Frontiers in immunology

Published: April 02, 2026

The hidden players: LncRNA-Encoded micropeptides in cancer hallmarks.

The hidden players: LncRNA-Encoded micropeptides in cancer hallmarks.

Journal: Cellular and molecular life sciences : CMLS

Published: November 06, 2025

Age-Related Survival Disparities in Advanced Renal Carcinoma in the Immune Checkpoint Inhibitor Era using the SEER Database and Meta-analysis.

Age-Related Survival Disparities in Advanced Renal Carcinoma in the Immune Checkpoint Inhibitor Era using the SEER Database and Meta-analysis.

Journal: Scientific reports

Published: December 30, 2024

Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma.

Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma.

Journal: Cancer cell international

Published: July 20, 2024

High RRM2 Correlates with Mitochondrial and Immune Responses in the Eosinophilic Subtype of Clear Cell Renal Cell Carcinoma.

High RRM2 Correlates with Mitochondrial and Immune Responses in the Eosinophilic Subtype of Clear Cell Renal Cell Carcinoma.

Journal: Journal of inflammation research

Published: July 16, 2024

GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells.

GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells.

Journal: Cancer cell international

Published: May 09, 2024

Identification and validation of sialyltransferase ST3Gal5 in bladder cancer through bioinformatics and experimental analysis.

Identification and validation of sialyltransferase ST3Gal5 in bladder cancer through bioinformatics and experimental analysis.

Journal: International immunopharmacology

Published: March 21, 2024

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer.

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer.

Journal: Bioengineering & translational medicine

Published: January 14, 2024

Prediction of bladder cancer prognosis and immune microenvironment assessment using machine learning and deep learning models.

Prediction of bladder cancer prognosis and immune microenvironment assessment using machine learning and deep learning models.

Journal: Heliyon

Published: January 12, 2024

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients.

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients.

Journal: Frontiers in immunology

Published: December 02, 2023

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study.

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study.

Journal: Cells

Published: October 08, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026